Could a $10 pill help cure HIV? early study launches
NCT ID NCT07415811
First seen Feb 21, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This small, early-stage study tests whether spironolactone, a cheap and FDA-approved blood pressure pill, can reduce the hidden HIV reservoir in people on successful HIV treatment. Researchers will give the drug to 12 adults (some with HIV, some without) and measure its effects on a key protein and viral activity. The goal is to gather safety and biological data to see if this drug could one day be part of an HIV cure strategy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grupo de Pesquisa Clínica em Moléstias Infecciosas
São Paulo, São Paulo, 05401000, Brazil
Conditions
Explore the condition pages connected to this study.